Connecting you with your industry every day
Following reports of eight deaths overseas, allegations trial results were manipulated plus regulatory action in the UK and Europe, this company has conducted a local assessment and decided to take the drug off the market
While this pharma has staved off a potentially hefty fine, it has agreed to a tough, legally binding agreement after an EU antitrust case
After 30 years working in innovative medicine companies, the decision for Nikki Lorenz to become a champion of the generics and biosimilars industry was a surprisingly easy one
A US company is ramping up its Australian commercialisation efforts for a gene therapy that won the Best Product for Orphan Disease at the 2026 Prix Galien UK Awards
Exactly one year after the late Professor challenged Australia to bring the same ambition to brain cancer that helped transform advanced melanoma, advocates are back at Parliament House
GSK's Australian Country Leader Andrew Thomas tells how being open to 'taking a shot' created a global high-flying career and offers tips on how pharma professionals can get ahead, in a new book called Work Fame
A strategy to protect market share for this oncology juggernaut has run into a major roadblock overseas and the same legal hurdle could hit Australia too
A UCB-sponsored report into the failings of paediatric medicine funding was launched in Parliament House today, attended by the heads of the Standing Committee on Health
Pioneering contributions to help eliminate malaria has earned this scientist Novo's coveted Young Women in Science Award plus $50K to continue her research
Talent movements across industry include a new role after redundancy, a move to a new country and leaving a company after 18 years
It's been a tough few years in pharma but this Australian recruitment expert warns that staying put in your current role just for job security is riskier than you think
This company has two generics ready to launch but has agreed to hold off ahead of a Full Federal Court hearing scheduled for next year in which a franchise worth $170M will be challenged
This agency alongside its pharma client have been awarded Bronze in Health Marketing, a category that finally returned to this year’s Australian Effie Awards
From 10 months to 10 weeks: national forum held at Parliament house looks to slash diagnosis time for juvenile arthritis in Australia
New Medicines Australia white paper calls for reforms to open more potentially life-saving cancer trials to Australian children
This company was found to have breached the Code of Practice after it voluntarily reported improperly disclosed grants worth more than $1.3M made more than four years ago
A court has ruled the channels to inform the public of a class action against Johnson & Johnson can include influencers in order to reach as many people as possible
Created to navigate the increasingly complex landscape of public health priorities, Government policy, public funding and the private market
Additional biosimilar brands targeting this lucrative franchise have been approved ahead of the PBAC's meeting next month which will consider them for PBS listing
STEM students tackle the impact of climate on Australia’s $100 billion agriculture industry and the trajectory of human health
Three departures including one redundancy as leaders across industry move on, taking decades of company history with them
After a significant stretch as one of industry's longest-serving ANZ Country Leaders this former GM has landed a new role
A new ranking reveals the lobbying firms most used by pharmaceutical companies to press their case with the Government - with one clearly ahead of the pack
Tens of thousands gain access to diabetes medications after Pharmac expands eligibility for funded treatments
The new radiopharma is backed by an investment syndicate led by 'Twiggy' Forrest's Tenmile with a mission to develop significant new medicines for hard-to-treat cancers
All high-strength formulations of this drug are set to be discontinued in Australia, with the TGA implementing Serious Scarcity Substitution to support ongoing patient access
Op-Ed: The return of Healthcare Marketing to Australia's prestigious Effie Awards means so much more than another gong for industry
While most specialists view MSLs positively almost a third describe their interactions as average or poor and almost one in three can't spot the difference between an MSL and Sales Rep
DBG Health has severed ties with Sam Wood, who faces two domestic violence charges, after it acquired the reality TV star’s exercise and nutrition program
Following an extended back-and-forth with the PBAC, this pharma appears to be progressing its new treatment towards a PBS listing